Cargando…

A Super TLR Agonist to Improve Efficacy of Dendritic Cell Vaccine in Induction of Anti-HCV Immunity

Persistent infections caused by pathogens such as hepatitis C virus are major human diseases with limited or suboptimal prophylactic and therapeutic options. Given the critical role of dendritic cell (DC) in inducing immune responses, DC vaccination is an attractive means to prevent and control the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Bangxing, Lee, Sung-Hyung, Song, Xiao-Tong, Jones, Lindsey, Machida, Keigo, Huang, Xue F., Chen, Si-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492467/ https://www.ncbi.nlm.nih.gov/pubmed/23144910 http://dx.doi.org/10.1371/journal.pone.0048614

Ejemplares similares

TLRs, Alcohol, HCV, and Tumorigenesis
por: Machida, Keigo
Publicado: (2010)

HCV and tumor-initiating stem-like cells
por: Machida, Keigo
Publicado: (2022)

The Role of Plasmacytoid and Myeloid Dendritic Cells in Induction of Asthma in a Mouse Model and the Effect of a TLR9 Agonist on Dendritic Cells
por: Mo, Ji-Hun, et al.
Publicado: (2011)

Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity
por: Jensen, Simon S, et al.
Publicado: (2010)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
por: Birmachu, Woubalem, et al.
Publicado: (2007)

TRIF Is a Critical Negative Regulator of TLR Agonist Mediated Activation of Dendritic Cells In Vivo
por: Seregin, Sergey S., et al.
Publicado: (2011)

Pharmacological inhibition of PI3K class III enhances the production of pro- and anti-inflammatory cytokines in dendritic cells stimulated by TLR agonists
por: Pittini, Álvaro, et al.
Publicado: (2016)

TLR3 Signaling Promotes the Induction of Unique Human BDCA-3 Dendritic Cell Populations
por: Colletti, Nicholas J., et al.
Publicado: (2016)

Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission
por: Beck, Barbara, et al.
Publicado: (2011)

Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists
por: Kamgang, Richard Kenmoe, et al.
Publicado: (2008)

Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients
por: Everson, Richard G., et al.
Publicado: (2023)

Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist
por: Lee, Young-Ran, et al.
Publicado: (2013)

TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells
por: Liu, Han, et al.
Publicado: (2016)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

Synergistic Induction of Interferon α through TLR-3 and TLR-9 Agonists Identifies CD21 as Interferon α Receptor for the B Cell Response
por: Kim, Dhohyung, et al.
Publicado: (2013)

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models
por: Crouse, Bethany, et al.
Publicado: (2023)

Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes
por: Hayashi, Tomoko, et al.
Publicado: (2015)

Induction of human tolerogenic dendritic cells by 3′-sialyllactose via TLR4 is explained by LPS contamination
por: Perdijk, Olaf, et al.
Publicado: (2017)

TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines
por: Israely, Tomer, et al.
Publicado: (2014)

A20 Controls Macrophage to Elicit Potent Cytotoxic CD4(+) T Cell Response
por: Wang, Lifeng, et al.
Publicado: (2012)

The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages
por: Yoshida, Sumito, et al.
Publicado: (2017)

L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells
por: Heo, Yoonki, et al.
Publicado: (2023)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions
por: Spirig, Rolf, et al.
Publicado: (2010)

Glycogen Metabolism Supports Early Glycolytic Reprogramming and Activation in Dendritic Cells in Response to Both TLR and Syk-Dependent CLR Agonists
por: Curtis, Kylie D., et al.
Publicado: (2020)

Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2/6 Agonists
por: Rasheed, Zahirrah B. M., et al.
Publicado: (2020)

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for T(H)1 Induction
por: Cauwelaert, Natasha Dubois, et al.
Publicado: (2016)

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
por: Tamir, Hadas, et al.
Publicado: (2022)

TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy
por: Gonzalez, Caleb, et al.
Publicado: (2023)

Effects of TLR agonists on immune responses in Trichinella spiralis infected mice
por: Tang, Bin, et al.
Publicado: (2020)

Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
por: Habchi, Jackie, et al.
Publicado: (2020)

Peptide Super-Agonist Enhances T-Cell Responses to Melanoma
por: Galloway, Sarah A. E., et al.
Publicado: (2019)

HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells
por: Chung, NP, et al.
Publicado: (2012)

Mycobacterium leprae induces a tolerogenic profile in monocyte‐derived dendritic cells via TLR2 induction of IDO
por: Oliveira, Jéssica A. P., et al.
Publicado: (2020)

Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease
por: Yu, Xiaocong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s347obuk6tl76csuujvnudd97l